$2.80
-0.05 (-1.75%)
Open$2.64
Previous Close$2.85
Day High$2.88
Day Low$2.64
52W High$7.92
52W Low$1.22
Volume—
Avg Volume28.2K
Market Cap35.54M
P/E Ratio—
EPS$-1.89
SectorBiotechnology
Analyst Ratings
Strong Buy
5 analysts
Price Target
+872.1% upside
Current
$2.80
$2.80
Target
$27.22
$27.22
$16.99
$27.22 avg
$37.92
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 192.0K | 117.8K | 4.38M |
| Net Income | -28,231,302 | -15,584,967 | -1,275,702 |
| Profit Margin | -14,755.4% | -14,017.6% | -29.1% |
| EBITDA | -34,182,312 | -19,918,540 | -1,970,058 |
| Free Cash Flow | — | — | -1,043,157 |
| Rev Growth | +63.0% | +63.0% | +7.3% |
| Debt/Equity | — | — | 0.26 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $249.46 | -0.54% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $415.21 | -0.63% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $138.36 | +0.16% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $505.75 | -2.07% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $803.48 | -0.31% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $228.65 | +0.67% | 35.2 | 28.41B |